Tightening the generics loophole
Mexico's patent regime had, until recently, created a situation that allowed untested generics to come to market. But, says Luis Schmidt, a recent change in the law should improve standards
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: